Meet OVELLE

OVELLE was created because the fertility supplement industry was stuck in the past—offering the same outdated solutions while breakthrough cellular research sat unused in academic journals.

In 2023, scientists discovered that the CD38 enzyme actively depletes NAD+ in aging ovaries, starving eggs of the cellular energy they need to develop properly. Around the same time, clinical trials showed resveratrol could improve egg quality in women with PCOS by restoring mitochondrial function. The science was clear, but no one was translating it into a product for women trying to conceive.

We built OVELLE Fertility to bridge that gap—combining research-backed NR and resveratrol at clinical doses to support egg quality at the cellular level. Not generic promises to "boost fertility naturally," but a targeted formula addressing what's actually happening in your ovaries as you age or face conditions like PCOS.

Our approach is simple: Evidence over hype. Transparency over proprietary blends. Education over fear-mongering. We tell you exactly why it works, show you third-party testing results, and give you a clear 8-12 week pre-conception protocol based on egg maturation biology—not open-ended supplementation designed to maximize our revenue.

Because when you're investing in your fertility journey, you deserve solutions that respect both the science and your intelligence.